Christopher Yoo Ph.D Overview
- Firm
- Yoo & Co Acceler...
- Primary Position
-
Founder & Chief...
- Primary Industry
-
Healthcare
- Active Board Seats
-
5
- Med. Deal Size
-
- Med. Valuation
-
Christopher Yoo Ph.D General Information
Biography
Dr. Christopher Yoo is the Founder and serves as Chief Executive Officer at Yoo & Co Accelerator. He serves as a Board Member at CRISPRQC. He is a Co-Founder and serves as Chief Technology Officer & Board Member at Systems Oncology. He also serves as a Board member at Lenoss Medical. He is the Founding Partner and serves as a General Partner at Xcellerant Ventures. He serves as a Board Member at Nanodropper. He is also a Co-Founder of Systems Imagination and serves as its Chief Executive Officer. He also is the Founder and serves as President and Chief Executive Officer at Yoo and Company. Previously he served as President and Chief Executive Officer at MedTrust Online. He has over 25 years of experience in advancing cutting-edge biomedical information technology. He is the founder and CEO of Systems Imagination, Inc., which offers advanced cognitive computing technology to translate big data into valuable insights. At IBM, he was instrumental as Head of Strategy and Planning for IBM's Information Based Medicine business, a new unit that pioneered the infusion of high-performance computing and research into the developing fields of personalized medicine and molecular therapeutics based on genomics. Throughout his career, he has also held leadership positions at Cisco, Oracle, and Applied Biosystems. As a serial entrepreneur, he has created value in new companies that accelerate the adoption of smarter, technology-based systems such as cognitive computing, big data analytics, and knowledge engineering. He has founded and successfully engineered the exit of startups including MedTrust Online, the world's first and largest online community of cancer doctors treating difficult cases with molecular medicine knowledge. He has also founded Golden Gateway Partners, a trans-Pacific technology consulting company, TransMed Partners, the first boutique consultancy for translational medicine, and LabBook, the first electronic laboratory notebook for HCLS researchers. In addition to his leadership roles at Systems Oncology and Systems Imagination, he is also a Faculty Associate in the College of Health Solutions at Arizona State University. He received his Ph.D. in Cell and Molecular Biology from Yale University and completed his postdoctoral fellowship at UC Berkeley.
Contact Information
Address
- 3110 North Central Avenue
- Street D-153
- Phoenix, AZ 85012
- United States
Christopher Yoo Ph.D Positions (4)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
ReSuture | Company | Board Member & Strategy Director | Surprise, AZ | Surgical Devices | |
Systems Oncology | Company | Co-Founder, Chief Technology Officer & Board Member | Scottsdale, AZ | Drug Discovery | |
Xcellerant Ventures | Investor | Founding Partner & General Partner | Scottsdale, AZ | Venture Capital | |
Yoo & Co Accelerator | Investor | Founder & Chief Executive Officer | Phoenix, AZ | Accelerator/Incubator |
Christopher Yoo Ph.D Board Seats (5)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
CRISPR QC | Other Healthcare Technology Systems | Privately Held (backing) | Venture Capital-Backed | San Diego, CA | |
Lenoss Medical | Other Devices and Supplies | Privately Held (backing) | Venture Capital-Backed | Providence, RI | |
Nanodropper | Other Devices and Supplies | Privately Held (backing) | Venture Capital-Backed | Rochester, MN | |
ReSuture | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Surprise, AZ | |
Systems Oncology | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Scottsdale, AZ |
Christopher Yoo Ph.D Lead Partner on Deals (5)
Christopher Yoo Ph.D has been the lead partner on 5 deals. Their latest deal was with CRISPR QC, a other healthcare technology systems company. The deal was made for on 02-Apr-2025.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
CRISPR QC | 02-Apr-2025 | Early Stage VC (Series A1) | Completed | Other Healthcare Technology Systems | San Diego, CA | |
Lenoss Medical | 13-Dec-2023 | Completed | Other Devices and Supplies | Providence, RI | ||
ReSuture | 06-Jun-2021 | Completed | Surgical Devices | Surprise, AZ | ||
Nanodropper | 19-Apr-2021 | Seed Round | Completed | Other Devices and Supplies | Rochester, MN | |
Nanodropper | Accelerator/Incubator | Completed | Other Devices and Supplies | Rochester, MN |
Christopher Yoo Ph.D Network (34)
Board Members (21)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Dominique Messerli | Lenoss Medical | Lenoss Medical | Providence, RI | |
Seema Phull | Nanodropper | Golden Seeds | Rochester, MN | |
Systems Oncology | Self | Scottsdale, AZ | ||
Nanodropper | Nanodropper | Rochester, MN | ||
Systems Oncology | The Pritzker Organization | Scottsdale, AZ |
Portfolio Executives (11)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Tim Cloutier Ph.D | CRISPR QC | Chief Commercial Officer | 02-Apr-2025 | San Diego, CA |
Kiana Aran Ph.D | CRISPR QC | Co-Founder & Board Member | 02-Apr-2025 | San Diego, CA |
CRISPR QC | Co-Founder, Chief Executive Officer, President & Board Member | 02-Apr-2025 | San Diego, CA | |
Lenoss Medical | Co-Founder, Chief Executive Officer, President & Chairman | 13-Dec-2023 | Providence, RI | |
ReSuture | Co-Founder, Chief Operating Officer & Board Member | 06-Jun-2021 | Surprise, AZ |
Fund Team Members (2)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Xcellerant Ventures | Scottsdale, AZ | ||
Xcellerant Ventures | Scottsdale, AZ |
Christopher Yoo Ph.D Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Xcellerant Fund 3 | Xcellerant Ventures | Venture - General | Open | 2023 |
Christopher Yoo Ph.D FAQs
-
Who is Christopher Yoo Ph.D?
Dr. Christopher Yoo is the Founder and serves as Chief Executive Officer at Yoo & Co Accelerator.
-
How much does Christopher Yoo Ph.D typically invest?
Christopher Yoo Ph.D's median deal size is
. -
What is Christopher Yoo Ph.D’s main position?
Christopher Yoo Ph.D’s primary position is Founder & Chief Executive Officer.
-
How many active board seats does Christopher Yoo Ph.D hold?
Christopher Yoo Ph.D holds 5 board seats including CRISPR QC, Lenoss Medical, Nanodropper, ReSuture, and Systems Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »